EP1833501A4 - Laminin receptor binding molecule - Google Patents

Laminin receptor binding molecule

Info

Publication number
EP1833501A4
EP1833501A4 EP05815992A EP05815992A EP1833501A4 EP 1833501 A4 EP1833501 A4 EP 1833501A4 EP 05815992 A EP05815992 A EP 05815992A EP 05815992 A EP05815992 A EP 05815992A EP 1833501 A4 EP1833501 A4 EP 1833501A4
Authority
EP
European Patent Office
Prior art keywords
binding molecule
receptor binding
laminin receptor
laminin
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05815992A
Other languages
German (de)
French (fr)
Other versions
EP1833501A1 (en
Inventor
Borhane Annabi
Chandra L Panchal
Jinzi Jason Wu
Richard Beliveau
Marcia Ruiz
Seema Garde
Mounia Bouzeghrane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kotinos Pharmaceuticals Inc
Original Assignee
Ambrilia Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2488777 external-priority patent/CA2488777A1/en
Application filed by Ambrilia Biopharma Inc filed Critical Ambrilia Biopharma Inc
Publication of EP1833501A1 publication Critical patent/EP1833501A1/en
Publication of EP1833501A4 publication Critical patent/EP1833501A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP05815992A 2004-12-01 2005-12-01 Laminin receptor binding molecule Withdrawn EP1833501A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA 2488777 CA2488777A1 (en) 2004-12-01 2004-12-01 Laminin receptor binding molecule
CA002502479A CA2502479A1 (en) 2004-12-01 2005-04-15 Laminin receptor binding molecule
PCT/CA2005/001831 WO2006058431A1 (en) 2004-12-01 2005-12-01 Laminin receptor binding molecule

Publications (2)

Publication Number Publication Date
EP1833501A1 EP1833501A1 (en) 2007-09-19
EP1833501A4 true EP1833501A4 (en) 2009-09-16

Family

ID=36564723

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05815992A Withdrawn EP1833501A4 (en) 2004-12-01 2005-12-01 Laminin receptor binding molecule

Country Status (3)

Country Link
EP (1) EP1833501A4 (en)
CA (1) CA2502479A1 (en)
WO (1) WO2006058431A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058353A1 (en) * 1998-12-10 2000-10-05 Shanghai Second Medical University Npcahh01: human transmembrane protein e3-16 gene
WO2002033090A2 (en) * 2000-10-16 2002-04-25 Procyon Biopharma Inc. Pharmaceutical preparations and methods for inhibiting tumors
WO2003039576A1 (en) * 2001-11-08 2003-05-15 Procyon Biopharma Inc. Psp-94: use for treatment of hypercalcemia and bone metastasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861710A (en) * 1986-09-26 1989-08-29 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA clone encoding laminin receptor
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5428011A (en) * 1992-06-16 1995-06-27 Procyon Biopharma, Inc. Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058353A1 (en) * 1998-12-10 2000-10-05 Shanghai Second Medical University Npcahh01: human transmembrane protein e3-16 gene
WO2002033090A2 (en) * 2000-10-16 2002-04-25 Procyon Biopharma Inc. Pharmaceutical preparations and methods for inhibiting tumors
WO2003039576A1 (en) * 2001-11-08 2003-05-15 Procyon Biopharma Inc. Psp-94: use for treatment of hypercalcemia and bone metastasis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2006058431A1 *
SHUKEIR NICHOLAS ET AL: "A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia", CANCER RESEARCH, vol. 64, no. 15, 1 August 2004 (2004-08-01), pages 5370 - 5377, XP002539049, ISSN: 0008-5472 *

Also Published As

Publication number Publication date
CA2502479A1 (en) 2006-06-01
WO2006058431A1 (en) 2006-06-08
EP1833501A1 (en) 2007-09-19

Similar Documents

Publication Publication Date Title
IL189519A0 (en) Chemokine receptor binding compounds
ZA201301416B (en) Binding molecules
HK1169418A1 (en) Tweak binding antibodies tweak
HK1155726A1 (en) Opioid receptor modulators
EP1896023A4 (en) Chemokine receptor binding compounds
EP1942890A4 (en) Chemokine receptor binding compounds
ZA200704526B (en) G Protein coupled receptor
GB0410627D0 (en) Specific binding members
EP2088860A4 (en) Chemokine receptor binding compounds
EP1833501A4 (en) Laminin receptor binding molecule
GB0414798D0 (en) Receptor
GB0516946D0 (en) Receptor
GB0413872D0 (en) Receptor
GB0427025D0 (en) Receptor
GB0423327D0 (en) Receptor
GB0417119D0 (en) Receptor
GB0413096D0 (en) Receptor
GB0404584D0 (en) Receptor
GB0404309D0 (en) Receptor
GB0522394D0 (en) Receptor
GB0522077D0 (en) Receptor
GB0522484D0 (en) Receptor
GB0510253D0 (en) Receptor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070627

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090819

17Q First examination report despatched

Effective date: 20091201

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KOTINOS PHARMACEUTICALS INC.

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111206